In this study, we demonstrated that SIRT1 activity was decreased in chagasic heart, and treatment with SIRT1 agonist during a therapeutic window, i.e., after the immune control of acute parasitemia and before the onset of myocarditis, was beneficial in preserving cardiac function in CCM. This evidence concerns the gene SIRT1 and myocarditis.